We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

This Upcoming Clinical Trial Will Assess the Use of Psychedelics for Fibromyalgia

The new open-label phase 2a trial will look at the use of an oral formulation of synthetic psilocybin and evaluate its safety and efficacy in a small number of patients with fibromyalgia.

Read More

Could Ketamine Help Treat Severe Depression?

Researchers from Trinity and St Patrick’s Mental Health Services are trialling a new treatment regime using ketamine for people who are experiencing severe depression.

Read More

Psilocybin Spurs Growth of Neural Connections Lost in Depression

The psychedelic drug psilocybin, a naturally occurring compound found in some mushrooms, has been shown to initiate an immediate and long-lasting increase in neural connections in mice.

Read More

LSD “Frees the Brain” From Its Usual Neural Pathways, Study Finds

The researchers also found that the drug increased the complexity of only certain brain states, known as segregated brain states.

Read More

Massachusetts General Hospital Launches New Center for Psychedelics

Analytical Cannabis spoke to Jerrold F. Rosenbaum, director of the Center for the Neuroscience of Psychedelics, to learn more about its research ambitions.

Read More

Single Dose of Psilocybin Can Remodel the Brains of Mice, Study Finds

The new study examined structural changes in the brain that might explain psilocybin’s enduring antidepressant effects.

Read More

Laughing Gas Relieves Symptoms of Treatment-Resistant Depression, New Study Finds

Results from a new clinical trial indicate that inhaling a mixture of 25 percent nitrous oxide and oxygen can provide long-lasting relief to those who have found other antidepressants ineffective.

Read More

Process By Which Ketamine Acts as an Antidepressant Confirmed

Ketamine can provide rapid antidepressant relief in as little as two hours that can be sustained for days to weeks.

Read More

More Than One-Third of Americans Support Psychedelics Legalization, New Poll Finds

The survey also found that 75 percent of respondents now support cannabis legalization for all purposes, with just 5 percent opposed to both recreational and medical legalization.

Read More

 
Advertisement